Physician profile
Tracy Mckenzie
NPI 1427897982
$797.42
in general payments reported to CMS, 2019-2025
18 companies · $557 in 2025
The $557 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $241 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $112.04 | 2024-2025 | |
| Abbvie INC. | $99.07 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $69.04 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Astrazeneca Pharmaceuticals LP | $49.18 | 2024-2025 | Airsupra, Breztri |
| Daiichi Sankyo INC. | $45.89 | 2024-2025 | Injectafer |
| Pfizer INC. | $45.81 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $42.64 | 2025 | Neffy |
| Boston Scientific Corporation | $39.73 | 2025 | Watchman Flx, Varithena Administration Pack |
| Novo Nordisk INC | $37.90 | 2025 | Wegovy, Ozempic |
| Abbott Laboratories | $36.85 | 2025 | Freestyle Libre 3 |
| Coloplast Corp | $36.16 | 2024 | |
| Lilly USA, LLC | $36.00 | 2024-2025 | Jardiance, Mounjaro |
| Amgen INC. | $33.77 | 2024-2025 | Repatha, Otezla, Otezla |
| Sumitomo Pharma America, INC. | $29.38 | 2025 | Gemtesa |
| Glaxosmithkline, LLC. | $27.58 | 2025 | Trelegy Ellipta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.44 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $18.49 | 2025 | Rexulti |
| Pulmonx Corporation | $16.45 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.